Find information on thousands of medical conditions and prescription drugs.

Cefotaxime

Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against Pseudomonas aeruginosa.

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Ceftriaxone vs. cefotaxime in abdominal surgery - Tips from Other Journals
From American Family Physician, 6/1/03 by Anne D. Walling

The third-generation cephalosporin antibiotics ceftriaxone and cefotaxime are widely used for prophylaxis in abdominal surgery. Both are active against a wide range of gram-positive and gram-negative organisms and have few side effects. The agents differ in cost and pharmacologic properties; 1 g of intravenous ceftriaxone has an average wholesale price of $46 compared with $12 for 1 g of intravenous cefotaxime. Woodfield and colleagues compared the prophylactic efficacy of these agents in more than 1,000 patients undergoing abdominal surgery.

They studied 1,013 adult patients admitted to a general surgery unit in New Zealand for acute or elective abdominal surgery. The patients were randomly assigned to prophylaxis with either agent after stratification to ensure that patients with particularly high risk of infection (e.g., colorectal resections) were equally distributed in both treatment groups. All patients received 1 g of the test agent intravenously at the induction of anesthesia, and patients in the highest risk group also were given 500 mg of metronidazole intravenously. Surgeons and staff did not know the patients' treatment allocations. Patients were followed for at least 30 days after surgery. The major outcome measured was wound infection with pus formation or cellulitis, and minor end points were yeast superinfection, deep peritoneal infection, chest infection, urinary tract infection, intravenous line sepsis, and other infections such as septicemia, infection of drain sites, and diarrhea resulting from Clostridium difficile.

Ninety-three patients were excluded from analysis because of death or a need for antibiotic therapy within 30 days of surgery without a wound infection. The 462 patients treated with ceftriaxone were comparable to the 458 patients treated with cefotaxime, except that cefotaxime was used slightly more frequently in urgent surgeries such as appendectomies. The overall wound infection rate was 8 percent for ceftriaxone compared with 12 percent for cefotaxime, but after adjustment for appendectomies performed without metronidazole coverage, the wound infection rates were similar (see accompanying table). The number of patients with chest or urinary tract infections was reduced significantly in the ceftriaxone group (6 percent compared with 11 percent in the cefotaxime group), and the percentage of patients who developed any infection also was reduced significantly with ceftriaxone (20 percent compared with 27 percent).

The authors conclude that ceftriaxone and cefotaxime provide effective prophylaxis for abdominal surgeries, but that cefotaxime does not provide adequate coverage for appendectomy without the addition of metronidazole. Overall, ceftriaxone was more effective, particularly against Staphylococcus aureus, and has a longer half-life and no active metabolites. Despite being more expensive, this agent may be a more versatile choice for antibiotic prophylaxis in abdominal surgery.

ANNE D. WALLING, M.D.

Woodfield JC, et al. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg January 2002;185:45-9.

COPYRIGHT 2003 American Academy of Family Physicians
COPYRIGHT 2003 Gale Group

Return to Cefotaxime
Home Contact Resources Exchange Links ebay